Sangamo Therapeutics Stock Price - SGMO

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
CHART Trader
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 8.32 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Sangamo Therapeutics Inc SGMO NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.315 -3.65% 8.315 8.66 8.275 8.54 8.63 23:59:49
Bid Price Ask Price Spread Spread % News
7.80 12.00 4.20 35.0% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6,035 847,671 $ 8.42 $ 7,138,136 1,217,331 6.26 - 14.79
Last Trade Time Type Quantity Stock Price Currency
16:00:00 formt 100 $ 8.315 USD

Sangamo Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 961.84M 115.68M $ -68.33M -0.71 - 113.60M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 14.00 1.80%

more financials information »

Sangamo Therapeutics News

Loading Messages....

Latest SGMO Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SGMO Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week8.168.697.948.29372M0.1551.90%
1 Month10.610.977.78.80601M-2.285-21.56%
3 Months11.8412.757.710.34341M-3.525-29.77%
6 Months11.6713.797.710.60021M-3.355-28.75%
1 Year14.6614.796.2610.82562M-6.345-43.28%
3 Years3.8527.52.6512.83602M4.465115.97%
5 Years10.4327.52.6511.83531M-2.115-20.28%

Sangamo Therapeutics Description

Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.

Your Recent History
Sangamo Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.